With more than 15 years of experience handling complex litigation, attorney Trent Miracle leads the firm’s Pharmaceutical Litigation Group, helping thousands of people harmed by dangerous drugs and defective medical devices.
Trent is a shareholder at Simmons Hanly Conroy LLC. Prior to joining the firm in 2003, Trent earned his bachelor’s degree in English from Depauw University in Indiana and graduated with his J.D. from St. Mary’s University School of Law in Texas in 1995. He began his career in 1996 as a personal injury attorney practicing aviation law, concentrating on airline and helicopter disasters.
Trent became a lawyer because he wanted to help people who have the odds stacked against them.
“I’ve worked with thousands of people who’ve been wronged by large companies,” he said. “You are not alone, but you alone can make the decision to stand up for yourself. Once you do that, we are here to help you with the rest.”
Under Trent’s leadership, the firm’s Pharmaceutical Group has grown from a single attorney and a handful of staff to a team of 7 attorneys and nearly 30 staff members. The pharmaceutical group has secured nearly $360 million in settlements on behalf of its clients harmed by pharmaceutical drugs like Bextra, Yaz, Vioxx, Ortho Evra, Ephedra and more.
“Because of the level of resources the firm dedicates to clients’ cases, my team and I are able to take on defendants at the national level,” Trent said.
The firm has built a national reputation as a leader in pharmaceutical injury litigation. Federal judges have appointed Trent to serve on plaintiff steering committees for several multidistrict litigations including Yaz, DePuy Hip Replacement, Propecia and more. In addition, he is regularly asked to speak at legal conferences and is the founding chairman of the American Association for Justice’s Asbestos Litigation Group.